The Division of Pharmacoepidemiology & Pharmacoeconomics at the Brigham and Women’s Hospital includes faculty and staff with backgrounds in internal medicine and its subspecialties, as well as epidemiology, health services research and policy, geriatrics, biostatistics, decision science, and public health. Major areas of research include: the scientific, policy, and social factors that influence physicians’ drug choices; medication compliance by patients; the identification and prevention of adverse drug effects; programs to improve the appropriateness of prescribing and drug taking; and pharmaceutical cost-effectiveness analysis. The Division also serves as a resource to the Brigham on appropriate medication use, and helps train its interns and residents in making optimal prescribing decisions.
Faculty Web Pages
- Division members launch the website for the Harvard Program on Perinatal and Pediatric Pharmacoepidemiology (H4P)
- DoPE Annual Report 2016
- Dr. Mike Fralick discusses a recent Big Data study on The Rounds Table
- Ameet Sarpatwari discusses the misuse of drug distribution schemes to forestall generic competition in the New York Times, AP, and Chemical and Engineering News
- NEJM Catalyst Free Live Web Event: Niteesh Choudhry to present, lead discussion, and share perspectives on quality and health care improvements through patient engagement
- Thomson Reuters: Avorn, Glynn, and Schneeweiss named to 2015 Highly Cited Researcher list